These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19505802)

  • 21. Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice.
    Lounis N; Bentoucha A; Truffot-Pernot C; Ji B; O'Brien RJ; Vernon A; Roscigno G; Grosset J
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3482-6. PubMed ID: 11709328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rifampicin activity "in vitro" and in established tuberculosis in mice.
    Verbist L
    Acta Tuberc Pneumol Belg; 1969; 60(3):397-412. PubMed ID: 4984420
    [No Abstract]   [Full Text] [Related]  

  • 23. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
    Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of time-dependent inhibition of polypeptide deformylase by actinonin.
    Van Aller GS; Nandigama R; Petit CM; DeWolf WE; Quinn CJ; Aubart KM; Zalacain M; Christensen SB; Copeland RA; Lai Z
    Biochemistry; 2005 Jan; 44(1):253-60. PubMed ID: 15628866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.
    Hearn MJ; Cynamon MH
    Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
    Dutta NK; Mazumdar K; Dastidar SG; Park JH
    Int J Antimicrob Agents; 2007 Oct; 30(4):336-40. PubMed ID: 17644321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)].
    Grosset J; Truffot C; Fermanian J; Lecoeur H
    Pathol Biol (Paris); 1982 Jun; 30(6):444-8. PubMed ID: 6810288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].
    Grumbach F; Canetti G; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):312-9. PubMed ID: 4994882
    [No Abstract]   [Full Text] [Related]  

  • 29. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.
    Andries K; Verhasselt P; Guillemont J; Göhlmann HW; Neefs JM; Winkler H; Van Gestel J; Timmerman P; Zhu M; Lee E; Williams P; de Chaffoy D; Huitric E; Hoffner S; Cambau E; Truffot-Pernot C; Lounis N; Jarlier V
    Science; 2005 Jan; 307(5707):223-7. PubMed ID: 15591164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis.
    Jayaram R; Shandil RK; Gaonkar S; Kaur P; Suresh BL; Mahesh BN; Jayashree R; Nandi V; Bharath S; Kantharaj E; Balasubramanian V
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2951-7. PubMed ID: 15273105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of 7-amino-4-methylcoumarin as an effective antitubercular agent: structure-activity relationships.
    Tandon R; Ponnan P; Aggarwal N; Pathak R; Baghel AS; Gupta G; Arya A; Nath M; Parmar VS; Raj HG; Prasad AK; Bose M
    J Antimicrob Chemother; 2011 Nov; 66(11):2543-55. PubMed ID: 21917615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.
    Rey-Jurado E; Tudó G; Martínez JA; González-Martín J
    Tuberculosis (Edinb); 2012 May; 92(3):260-3. PubMed ID: 22342247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid.
    Quenelle DC; Winchester GA; Staas JK; Barrow EL; Barrow WW
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1637-44. PubMed ID: 11353605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tuberculosis activity and drug interaction with nevirapine of inhalable lipid microspheres containing rifampicin in murine model.
    Disratthakit A; Doi N; Takenaga M; Ohta Y
    J Microencapsul; 2010; 27(4):365-71. PubMed ID: 20392161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
    Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection.
    Rodrigues-Junior VS; Dos Santos Junior A; Dos Santos AJ; Schneider CZ; Calixto JB; Sousa EH; de França Lopes LG; Souto AA; Basso LA; Santos DS; Campos MM
    Int J Antimicrob Agents; 2012 Aug; 40(2):182-5. PubMed ID: 22748570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Activities of clofazimine against Mycobacterium tuberculosis in vitro and in vivo].
    Lu Y; Zheng MQ; Wang B; Zhao WJ; Li P; Chu NH; Liang BW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Oct; 31(10):752-5. PubMed ID: 19080601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycine in the conserved motif III modulates the thermostability and oxidative stress resistance of peptide deformylase in Mycobacterium tuberculosis.
    Narayanan SS; Sokkar P; Ramachandran M; Nampoothiri KM
    FEMS Microbiol Lett; 2011 Jul; 320(1):40-7. PubMed ID: 21507054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy using IL-2 and GM-CSF is a potential treatment for multidrug-resistant Mycobacterium tuberculosis.
    Zhang Y; Liu J; Wang Y; Xian Q; Shao L; Yang Z; Wang X
    Sci China Life Sci; 2012 Sep; 55(9):800-6. PubMed ID: 23015129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.
    Sriram D; Yogeeswari P; Yelamanchili Priya D
    Biomed Pharmacother; 2009 Jan; 63(1):36-9. PubMed ID: 18343086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.